BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 6177786)

  • 1. Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.
    Lukehart SA; Baker-Zander SA; Gubish ER
    J Immunol; 1982 Aug; 129(2):833-8. PubMed ID: 6177786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antigenic interrelationship between the endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum Nichols strain. I. Treponemicidal activity of cross-reactive endoflagellar antibodies against T. pallidum.
    Blanco DR; Radolf JD; Lovett MA; Miller JN
    J Immunol; 1986 Nov; 137(9):2973-9. PubMed ID: 3531343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The axial filament antigen of Treponema pallidum.
    Penn CW; Bailey MJ; Cockayne A
    Immunology; 1985 Apr; 54(4):635-41. PubMed ID: 3884491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response in experimental syphilis to polypeptides of Treponema pallidum.
    Hanff PA; Bishop NH; Miller JN; Lovett MA
    J Immunol; 1983 Oct; 131(4):1973-7. PubMed ID: 6352809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response in human syphilis to polypeptides of Treponema pallidum.
    Hanff PA; Fehniger TE; Miller JN; Lovett MA
    J Immunol; 1982 Sep; 129(3):1287-91. PubMed ID: 7050242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic interrelationship between endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum (Nichols): molecular characterization of endoflagellar proteins.
    Radolf JD; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 1986 Dec; 54(3):626-34. PubMed ID: 2430886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies to Treponema pallidum.
    Lukehart SA; Tam MR; Hom J; Baker-Zander SA; Holmes KK; Nowinski RC
    J Immunol; 1985 Jan; 134(1):585-92. PubMed ID: 3880576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum (Nichols).
    Jones SA; Marchitto KS; Miller JN; Norgard MV
    J Exp Med; 1984 Nov; 160(5):1404-20. PubMed ID: 6208310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of antigens from Treponema phagedenis biotype Reiter cross-reacting with Treponema pallidum.
    Petersen CS
    Dan Med Bull; 1986 Oct; 33(5):257-65. PubMed ID: 3536339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic complexity of Treponema pallidum: antigenicity and surface localization of major polypeptides.
    Norris SJ; Sell S
    J Immunol; 1984 Nov; 133(5):2686-92. PubMed ID: 6207241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of a Reiter treponemal protein antigen that is immunologically related to an antigen in Treponema pallidum.
    Petersen CS; Pedersen NS; Axelsen NH
    Infect Immun; 1982 Mar; 35(3):974-8. PubMed ID: 6175580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of immunological cross-reactivity between Treponema pallidum and Treponema pertenue.
    Baker-Zander SA; Lukehart SA
    Infect Immun; 1983 Nov; 42(2):634-8. PubMed ID: 6358028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive cross reactivity between Treponema pallidum and cultivable treponemes demonstrated by sequential immunoadsorption.
    Wos SM; Wicher K
    Int Arch Allergy Appl Immunol; 1986; 79(3):282-5. PubMed ID: 3512456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation limits the rate of in vitro treponemicidal activity and correlates with antibody-mediated aggregation of Treponema pallidum rare outer membrane protein.
    Blanco DR; Walker EM; Haake DA; Champion CI; Miller JN; Lovett MA
    J Immunol; 1990 Mar; 144(5):1914-21. PubMed ID: 2407784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of glycosylated protein antigens of Treponema pallidum and Treponema phagedenis.
    Moskophidis M; Müller F
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):468-76. PubMed ID: 3901616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic contents of Treponema pallidum preparations.
    Wos SM; Wicher K
    Genitourin Med; 1986 Apr; 62(2):71-4. PubMed ID: 3522410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic cross-reactivity between Treponema pallidum and other pathogenic members of the family Spirochaetaceae.
    Baker-Zander SA; Lukehart SA
    Infect Immun; 1984 Oct; 46(1):116-21. PubMed ID: 6384040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of antibody response to polypeptides of pathogenic and nonpathogenic treponemes in experimental syphilis.
    Wicher K; Wos SM; Wicher V
    Sex Transm Dis; 1986; 13(4):251-7. PubMed ID: 3544258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral response in Treponema pallidum-infected guinea pigs: I. Antibody specificity.
    Wicher K; Jakubowski A; Wicher V
    Clin Exp Immunol; 1987 Aug; 69(2):263-70. PubMed ID: 3308224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of treponemicidal activity in normal human serum with the presence of IgG antibody directed against polypeptides of Treponema phagedenis biotype Reiter and Treponema pallidum, Nichols strain.
    Blanco DR; Radolf JD; Lovett MA; Miller JN
    J Immunol; 1986 Sep; 137(6):2031-6. PubMed ID: 3528292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.